Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kenichi Manabe is active.

Publication


Featured researches published by Kenichi Manabe.


American Journal of Cardiology | 2010

Contrast-Induced Nephropathy in Patients Undergoing Emergency Percutaneous Coronary Intervention for Acute Coronary Syndrome

Takeshi Senoo; Masayuki Motohiro; Hiroshi Kamihata; Satoshi Yamamoto; Tsuyoshi Isono; Kenichi Manabe; Takao Sakuma; Susumu Yoshida; Yasuo Sutani; Toshiji Iwasaka

Contrast-induced nephropathy (CIN) is associated with significantly increased morbidity and mortality after coronary angiography and percutaneous coronary intervention (PCI). The aim of the present study was to assess the clinical features and in-hospital outcomes of CIN after emergency PCI. The serum creatinine (SCr) concentration was measured from days 0 to 30 in 338 consecutive patients with acute coronary syndrome undergoing emergency PCI. CIN was defined as an increase in SCr of >25% or >0.5 mg/dl within 2 days after PCI. Overall, 94 patients (28%) developed CIN. The mean SCr on admission was not significantly different between patients with CIN and those without CIN. The CIN group had significantly greater SCr at days 1, 2, and 30 than did the no CIN group. Multivariate analysis showed female gender (odds ratio [OR] 2.38, 95% confidence interval [CI] 1.12 to 5.07, p = 0.025), a culprit lesion in the left anterior descending artery (OR 2.37, 95% CI 1.31 to 4.27, p = 0.0042), contrast agent volume >200 ml (OR 3.60, 95% CI 1.96 to 6.62, p <0.001) and end-diastolic pulmonary arterial pressure >15 mm Hg (OR 2.03, 95% CI 1.02 to 4.04, p <0.01) to all correlate independently with CIN. The in-hospital mortality rate was greater in the CIN group than in the no CIN group (9.6% vs 3.3%, respectively; p = 0.025). In conclusion, CIN is a frequent complication of emergency PCI for acute coronary syndrome and is associated with a greater mortality rate and persistent renal dysfunction.


European Journal of Clinical Investigation | 2012

Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.

Kenichi Manabe; Hiroshi Kamihata; Masayuki Motohiro; Takeshi Senoo; Susumu Yoshida; Toshiji Iwasaka

Eur J Clin Invest 2012; 42 (5): 557–563


Journal of Cardiology | 2009

Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency

Susumu Yoshida; Hiroshi Kamihata; Seishi Nakamura; Takeshi Senoo; Kenichi Manabe; Masayuki Motohiro; Tetsuro Sugiura; Toshiji Iwasaka

BACKGROUND Contrast-induced nephropathy (CIN) is known to increase morbidity and mortality of cardiovascular disease. Recent studies have shown statins prevented CIN after contrast media exposure, but optimal statin type and dosage are still unknown. PURPOSE The aims of the present study were to evaluate whether chronic pravastatin treatment before scheduled coronary angiography or percutaneous coronary intervention could reduce the incidence of CIN and to elucidate the factors related to CIN in patients with renal insufficiency. METHODS We studied 431 consecutive patients with renal insufficiency. One hundred ninety-four patients were receiving pravastatin treatment as standard chronic treatment of hypercholesterolemia. Serum creatinine levels were measured at baseline (pre-procedure) and within 48 h after contrast media exposure (peak post-procedure). CIN was defined as an increase in the serum creatinine values of > or = 25% or > or = 0.5 mg/dl after contrast media exposure. Logistic regression analysis was performed to evaluate the important factors related to CIN using four variables: age, pravastatin, pre-procedure serum creatinine, and contrast volume. RESULTS CIN was observed in 36 patients (8.4%). Patients without pravastatin (p<0.01), high level pre-procedure serum creatinine (p<0.01), and high contrast volume (p=0.034) had a significantly higher incidence of CIN. Logistic regression analysis revealed that pravastatin treatment (chi(2)=6.549, p=0.011, odds ratio=0.34), pre-procedure serum creatinine (chi(2)=6.294, p=0.009, odds ratio=2.78), and contrast volume (chi(2)=4.484, p=0.034, odds ratio=1.01) were independently related to the decreased risk of CIN. CONCLUSIONS Chronic pravastatin treatment before contrast media exposure was important for preventing CIN in patients with renal insufficiency. Also, reducing the dose of contrast media was important for preventing CIN in patients with high-baseline serum creatinine levels.


American Journal of Cardiology | 2011

A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography.

Masayuki Motohiro; Hiroshi Kamihata; Satoshi Tsujimoto; Takeshi Seno; Kenichi Manabe; Tsuyoshi Isono; Yasuo Sutani; Fumio Yuasa; Toshiji Iwasaka

Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality rates. Although a previous study reported that pretreatment with sodium bicarbonate is more effective than sodium chloride for prophylaxis of CIN, this has not been a universal finding. We performed a prospective randomized trial to investigate whether CIN can be avoided using sodium bicarbonate. In total 155 patients with a glomerular filtration rate (GFR) <60 ml/min/1.73 m(2) who were undergoing coronary angiography were enrolled. We assigned patients to sodium chloride plus sodium bicarbonate (bicarbonate group, n = 78) or sodium chloride alone (chloride group, n = 77). Infusion of sodium bicarbonate at 1 ml/kg/hour continued from 3 hours before to 6 hours after coronary angiography. CIN was defined as a 25% increase in serum creatinine from baseline value or an absolute increase of ≥0.5 mg/dl, which appeared within 2 days of contrast. Baseline GFR was not significantly different between the 2 groups. Patients in the bicarbonate group had a higher GFR than those in the chloride group on day 2 (45.8 ± 13.4 vs 40.9 ± 14.6 ml/min/1.73 m(2), p = 0.031) and at 1 month (49.5 ± 14.7 vs 43.7 ± 15.5 ml/min/1.73 m(2), p = 0.019). CIN occurred in 10 patients (13%) in the chloride group but in only 2 patients (2.6%) in the bicarbonate group (p = 0.012). Sodium chloride plus sodium bicarbonate is more effective than sodium chloride alone for prophylaxis of CIN and can lead to retention of better long-term renal function.


Platelets | 2006

Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris

Norihito Inami; Shosaku Nomura; Kenichi Manabe; Yutaka Kimura; Toshiji Iwasaka

Inflammation plays a pathogenic role in the development of restenosis after percutaneous coronary intervention (PCI). We measured and compared the ratio of elevated levels of regulated on activation normally T-cell expressed and secreted (RANTES), monocytic chemotactic peptide-1 (MCP-1), soluble (s) P-selectin and sL-selectin after PCI. Plasma levels of chemokines and soluble markers were measured before, 1, 3 and 7 days after PCI in 52 patients (43 males and nine females, aged 63 ± 10 years) who underwent PCI and who had repeated angiograms at a 6-month follow-up. Restenosis occurred in 16 (31%) patients. A significant and time-dependent increase in sL-selectin was observed in the restenosis group. However, there were no significant differences in MCP-1 levels with or without restenosis. sP-selectin levels in the restenosis group exhibited a transient elevation at 3 days after PCI. RANTES levels were no different at baseline between patients with or without restenosis. However, a significant and time-dependent decrease in RANTES levels were observed in the non-restenosis group, and patients with restenosis compared with patients without restenosis had a statistically significant ratio of elevated levels of RANTES. These findings suggest that restenosis development after PCI in patients with effort angina pectoris may involve leukocyte activation at an early period after PCI. In addition, platelet-derived chemokine RANTES may be a sign of restenosis after PCI in patients with stable angina pectoris.


Japanese journal of geriatrics | 2014

Tuberculosis of the thyroid gland mimicking thyroid carcinoma in the elderly

Tetsuji Niiya; Eriko Kawamoto; Sayaka Watanabe; Hitomi Sakao; Kenichi Manabe; Akiko Ogawa; Shinya Furukawa

A 76-year-old woman with a 10-year history of chronic glomerulonephritis was treated at a clinic after presenting with a gradual worsening of the renal function. The patient had no history of tuberculosis. She was subsequently hospitalized for uremic symptoms and treated with internal shunt insertion and dialysis. Thyroid ultrasonography was performed to screen for secondary hyperparathyroidism, which revealed a calcified thyroid mass and cervical lymph node swelling. Fine-needle aspiration biopsy was thus conducted to assess suspected thyroid cancer. The cytological findings showed few follicular epithelial cells, without any signs of malignancy. However, a diagnosis of thyroid cancer continued to be strongly suspected based on the imaging features. Total thyroidectomy and bilateral cervical regional lymph node dissection were therefore performed, and the pathological examination of the thyroidectomy specimen disclosed scattered epithelioid granulomas with caseous necrosis in the entire right lobe as well as the cervical lymph nodes. Based on these findings, the patient was diagnosed with thyroid tuberculosis. As the symptoms and imaging findings of tuberculosis are nonspecific in elderly patients, it is necessary to consider this disease in this population. We therefore propose the inclusion of thyroid tuberculosis in the differential diagnosis of elderly patients who present with malignant thyroid tumors on aspiration biopsy cytology, regardless of whether or not they have a previous history of tuberculosis.


Journal of Thrombosis and Thrombolysis | 2007

Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervension in patients with coronary artery disease

Norihito Inami; Shosaku Nomura; Takayuki Shimazu; Kenichi Manabe; Yutaka Kimura; Toshiji Iwasaka


Japanese journal of geriatrics | 2013

[Incidence and clinical outcome of contrast-induced nephropathy in the elderly patients].

Masayuki Motohiro; Hiroshi Kamihata; Yoshinori Suwa; Kousuke Murakawa; Satoshi Tsujimoto; Shigeo Umemura; Kenichi Manabe; Toshiji Iwasaka; Ichiro Shiojima


Japanese journal of geriatrics | 2013

Fulminant type 1 diabetes in an elderly patient treated after receiving a diagnosis of type 2 diabetes

Akiko Ogawa; Tetsuji Niiya; Kenichi Manabe; Eriko Kawamoto


Journal of the American College of Cardiology | 2014

TCTAP A-076 Urinary L-FABP Predicts Survival Outcome Before Contrast Agent Administration in Patients with Chronic Kidney Disease

Kenichi Manabe; Hiroshi Kamihata; Masayuki Motohiro; Takeshi Senoo; Susumu Yoshida; Shigeo Umemura; Satoshi Tsujimoto; Ichiro Shiojima

Collaboration


Dive into the Kenichi Manabe's collaboration.

Top Co-Authors

Avatar

Toshiji Iwasaka

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takeshi Senoo

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susumu Yoshida

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Yoshiji Iharada

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Tsuyoshi Isono

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Yutaka Kimura

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Seiji Matsuhisa

Kansai Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge